Hemostemix Inc. (TSXV: HEM / OTC: HMTXF) – Awaiting Results of Phase II Trials of a Potential Therapy for Cardiovascular Diseases – Initiating Coverage
Highlights Based out of Alberta, this company is a clinical-stage (pre-revenue) biotechnology...
Read More